{"protocolSection": {"identificationModule": {"nctId": "NCT01248065", "orgStudyIdInfo": {"id": "AsthmaNet 001"}, "secondaryIdInfos": [{"id": "1U10HL098115", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/1U10HL098115"}], "organization": {"fullName": "Milton S. Hershey Medical Center", "class": "OTHER"}, "briefTitle": "Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma", "officialTitle": "Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma", "acronym": "VIDA"}, "statusModule": {"statusVerifiedDate": "2014-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-04"}, "primaryCompletionDateStruct": {"date": "2014-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-11-24", "studyFirstSubmitQcDate": "2010-11-24", "studyFirstPostDateStruct": {"date": "2010-11-25", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-06-18", "resultsFirstSubmitQcDate": "2014-07-23", "resultsFirstPostDateStruct": {"date": "2014-08-13", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2014-07-23", "lastUpdatePostDateStruct": {"date": "2014-08-13", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "dave mauger", "investigatorTitle": "Principal Investigator, AsthmaNet Data Coordinating Center", "investigatorAffiliation": "Milton S. Hershey Medical Center"}, "leadSponsor": {"name": "Milton S. Hershey Medical Center", "class": "OTHER"}, "collaborators": [{"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of the study is to find out if taking vitamin D in addition to an asthma controller medication helps to prevent worsening of asthma symptoms and asthma attacks.", "detailedDescription": "This is a randomized, double-blind parallel group trial that will enroll individuals who have vitamin D insufficiency and asthma with persistent symptoms despite low-dose inhaled corticosteroid. Participants on low-dose inhaled corticosteroid will be randomized to add-on therapy with either placebo or high-dose vitamin D for a 28-week period. During the inhaled corticosteroid-stable phase, participants will remain on low-dose inhaled corticosteroid. During the inhaled corticosteroid-taper phase, participants will taper their inhaled corticosteroid by 50% at two time-points post-randomization. The investigators will determine if the addition of vitamin D reduces the likelihood of treatment failure when compared to placebo during both the inhaled corticosteroid-stable and inhaled corticosteroid-taper phases of the study. Given the high prevalence of both vitamin D insufficiency and asthma, this trial has high potential to impact daily asthma management."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "Vitamin D", "Corticosteroids", "Treatment failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 408, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Ciclesonide + placebo", "type": "PLACEBO_COMPARATOR", "interventionNames": ["Drug: Ciclesonide"]}, {"label": "Ciclesonide + Vitamin D", "type": "EXPERIMENTAL", "interventionNames": ["Drug: Vitamin D3", "Drug: Ciclesonide"]}], "interventions": [{"type": "DRUG", "name": "Vitamin D3", "description": "vitamin D (100,000 IU loading dose followed by 4,000 IU/day)", "armGroupLabels": ["Ciclesonide + Vitamin D"]}, {"type": "DRUG", "name": "Ciclesonide", "description": "Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)", "armGroupLabels": ["Ciclesonide + Vitamin D", "Ciclesonide + placebo"], "otherNames": ["Alvesco\u00ae"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Treatment Failure", "description": "Treatment failure is a well-defined asthma outcome reflecting overall asthma control that has been used previously in multiple clinical trials. Treatment failure as defined in the current proposal and prior trials is consistent with the American Thoracic Society (ATS)/European Respiratory Society(ERS) definition of a moderate exacerbation - a deterioration in symptoms and/or lung function with increased rescue bronchodilator use that lasts 2 days or more. The percentages of participants experiencing a treatment failure are Kaplan-Meier estimates of failure rate.", "timeFrame": "Twenty-eight week intervention period from randomization until end of trial."}], "secondaryOutcomes": [{"measure": "Lung Function Change From Baseline", "description": "FEV1 (liters) and methacholine PC20 will be evaluated. Changes are measured as 28 weeks minus baseline.", "timeFrame": "Change is measured as value at 28 weeks minus baseline value."}, {"measure": "Exacerbations", "description": "Outcome defined as number of exacerbations per person-year.", "timeFrame": "Overall exacerbation rate during 28-week trial"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Men and women 18 years of age and older\n* Physician-diagnosed asthma for at least previous 12 months\n* Asthma confirmed by: (a) \u03b2-agonist reversibility of forced expiratory volume in 1 second (FEV1) \u226512 % following 180 mcg (4 puffs) levalbuterol at visit 1 OR (b) methacholine provocative concentration causing a 20% fall in FEV1 (PC20) \u2264 8 mg/ml if not receiving an inhaled corticosteroid or \u2264 16 mg/ml if receiving an inhaled corticosteroid at visit 2. Source documentation for PC20 from an AsthmaNet methacholine challenge completed within 6 months of visit 2 will be accepted.\n* Stable asthma controller therapy (inhaled corticosteroid or leukotriene modifier only) dose for past 2 weeks\n* FEV1 \u2265 50% of predicted at visit 1\n* Vitamin D level of less than 30 ng/ml at visit 0\n* Experienced no more than one treatment failure in the VIDA run-in or oral corticosteroid (OCS) response periods on previous enrollments\n* For women of childbearing potential: not pregnant, non-lactating, and agree to practice an adequate birth control method for the duration of the study\n\nExclusion Criteria:\n\n* Taking vitamin D supplements containing \\> 1000 IU/day of vitamin D\n* Taking \\>2500 mg/day calcium supplements\n* Chronic oral corticosteroid therapy\n* Chronic inhaled corticosteroid therapy \\> 1,000 mcg of fluticasone daily or the equivalent\n* History of physician-diagnosed nephrolithiasis\n* Use of concomitant medications that alter vitamin D metabolism - phenytoin, phenobarbital, cardiac glycosides; or absorption - orlistat, cholestyramine, colestipol; or those that interfere with study endpoints\n* Impaired renal function (GFR \\< 30 ml/min)\n* Asthma exacerbation within past 4 weeks requiring systemic corticosteroids\n* Respiratory tract infection within past 4 weeks\n* Chronic diseases (other than asthma)\n* History of cigarette smoking within the past 1 year or \\> 10 pack years total\n* Serum calcium greater than 10.2 mg/dl on entry\n* Urine calcium/creatinine ratio greater than 0.37 (urinary Ca and Creat in mg)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "David T. Mauger, PhD", "affiliation": "Pennsylvania State University College of Medicine", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Elliot Israel, MD", "affiliation": "Brigham and Women's Hospital", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Lewis Smith, MD", "affiliation": "Northwestern Memorial Hospital", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Julian Solway, MD", "affiliation": "University of Chicago", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "James Moy, MD", "affiliation": "Rush University Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Richard Martin, MD", "affiliation": "National Jewish Health", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Christine Sorkness, MD", "affiliation": "University of Wisconsin, Madison", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Elizabeth Bade, MD", "affiliation": "Aurora Sinai Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sally Wenzel, MD", "affiliation": "University of Pittsburgh Medical Center", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "James Chmiel, MD", "affiliation": "Case Western Reserve University School of Medicine", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Mario Castro, MD", "affiliation": "Washington University School of Medicine", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Homer Boushey, MD", "affiliation": "University of California, San Francisco", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Monica Kraft, MD", "affiliation": "Duke University", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Stephen Peters, MD", "affiliation": "Wake Forest University Health Sciences", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "W. Gerald Teague, MD", "affiliation": "University of Virginia Health System", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Craig LaForce, MD", "affiliation": "North Carolina Clinical Research", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Anne Fitzpatrick, MD", "affiliation": "Emory University", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Jerry Krishnan, MD", "affiliation": "University of Illinois at Chicago", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of California - San Francisco", "city": "San Francisco", "state": "California", "zip": "94143", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "National Jewish Health", "city": "Denver", "state": "Colorado", "zip": "80206", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Emory University", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Northwestern Memorial Hospital", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Rush University Medical Center/Stroger Hospital", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Illinois at Chicago", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Chicago", "city": "Chicago", "state": "Illinois", "zip": "60637", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Brigham and Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Washington University", "city": "St. Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Duke University School of Medicine", "city": "Durham", "state": "North Carolina", "zip": "27110", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "North Carolina Clinical Research", "city": "Raleigh", "state": "North Carolina", "zip": "27607", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"facility": "Wake Forest University Health Sciences", "city": "Winston-Salem", "state": "North Carolina", "zip": "27157", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"facility": "Rainbow Babies and Children's Hospital", "city": "Cleveland", "state": "Ohio", "zip": "44106", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "University of Pittsburgh", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15213", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "University of Wisconsin-Madison", "city": "Madison", "state": "Wisconsin", "zip": "53792", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "Aurora Sinai Medical Center", "city": "Milwaukee", "state": "Wisconsin", "zip": "53233", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "26971692", "type": "DERIVED", "citation": "Jiao J, King TS, McKenzie M, Bacharier LB, Dixon AE, Codispoti CD, Dunn RM, Grossman NL, Lugogo NL, Ramratnam SK, Traister RS, Wechsler ME, Castro M; National Heart, Lung, and Blood Institute's AsthmaNet. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. J Allergy Clin Immunol. 2016 Aug;138(2):589-592.e2. doi: 10.1016/j.jaci.2015.12.1329. Epub 2016 Mar 11. No abstract available."}, {"pmid": "24838406", "type": "DERIVED", "citation": "Castro M, King TS, Kunselman SJ, Cabana MD, Denlinger L, Holguin F, Kazani SD, Moore WC, Moy J, Sorkness CA, Avila P, Bacharier LB, Bleecker E, Boushey HA, Chmiel J, Fitzpatrick AM, Gentile D, Hundal M, Israel E, Kraft M, Krishnan JA, LaForce C, Lazarus SC, Lemanske R, Lugogo N, Martin RJ, Mauger DT, Naureckas E, Peters SP, Phipatanakul W, Que LG, Sheshadri A, Smith L, Solway J, Sullivan-Vedder L, Sumino K, Wechsler ME, Wenzel S, White SR, Sutherland ER; National Heart, Lung, and Blood Institute's AsthmaNet. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA. 2014 May;311(20):2083-91. doi: 10.1001/jama.2014.5052."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "FG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "207"}, {"groupId": "FG001", "numSubjects": "201"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "comment": "All 207 participants were included in the primary time-to-event analysis.", "numSubjects": "181"}, {"groupId": "FG001", "comment": "All 201 participants were included in the primary time-to-event analysis.", "numSubjects": "179"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "26"}, {"groupId": "FG001", "numSubjects": "22"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "11"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Third treatment failure event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "5"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "BG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "207"}, {"groupId": "BG001", "value": "201"}, {"groupId": "BG002", "value": "408"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "39.5", "spread": "12.7"}, {"groupId": "BG001", "value": "39.9", "spread": "13.1"}, {"groupId": "BG002", "value": "39.7", "spread": "12.9"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "141"}, {"groupId": "BG001", "value": "137"}, {"groupId": "BG002", "value": "278"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "66"}, {"groupId": "BG001", "value": "64"}, {"groupId": "BG002", "value": "130"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Asian/Pacific Islander", "categories": [{"measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "14"}]}]}, {"title": "Black", "categories": [{"measurements": [{"groupId": "BG000", "value": "68"}, {"groupId": "BG001", "value": "63"}, {"groupId": "BG002", "value": "131"}]}]}, {"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "111"}, {"groupId": "BG001", "value": "105"}, {"groupId": "BG002", "value": "216"}]}]}, {"title": "Hispanic", "categories": [{"measurements": [{"groupId": "BG000", "value": "19"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "39"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "8"}]}]}]}, {"title": "Duration of asthma", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "25.0", "spread": "12.8"}, {"groupId": "BG001", "value": "24.9", "spread": "13.5"}, {"groupId": "BG002", "value": "25.0", "spread": "13.2"}]}]}]}, {"title": "Body mass index", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "kg/m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "31.5", "spread": "9.5"}, {"groupId": "BG001", "value": "32.0", "spread": "8.2"}, {"groupId": "BG002", "value": "31.8", "spread": "8.9"}]}]}]}, {"title": "Symptom score (morning)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Avg score of 5 sx: 0=absent to 3=severe", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0.41", "spread": "0.36"}, {"groupId": "BG001", "value": "0.41", "spread": "0.34"}, {"groupId": "BG002", "value": "0.41", "spread": "0.35"}]}]}]}, {"title": "Symptom score (afternoon and evening)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Avg score of 5 sx: 0=absent to 3=severe", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0.43", "spread": "0.40"}, {"groupId": "BG001", "value": "0.44", "spread": "0.35"}, {"groupId": "BG002", "value": "0.43", "spread": "0.37"}]}]}]}, {"title": "Level of 25-hydroxyvitamin D", "paramType": "MEDIAN", "dispersionType": "INTER_QUARTILE_RANGE", "unitOfMeasure": "ng/mL", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "18.8", "lowerLimit": "13.4", "upperLimit": "23.7"}, {"groupId": "BG001", "value": "19.9", "lowerLimit": "14.5", "upperLimit": "25.0"}, {"groupId": "BG002", "value": "19.2", "lowerLimit": "13.9", "upperLimit": "24.3"}]}]}]}, {"title": "FEV1 before albuterol use (L)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "liters", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "2.62", "spread": "0.83"}, {"groupId": "BG001", "value": "2.63", "spread": "0.78"}, {"groupId": "BG002", "value": "2.63", "spread": "0.80"}]}]}]}, {"title": "FEV1 before albuterol use (% predicted)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "% predicted", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "80.5", "spread": "14.2"}, {"groupId": "BG001", "value": "80.7", "spread": "13.8"}, {"groupId": "BG002", "value": "80.6", "spread": "14.0"}]}]}]}, {"title": "Methacholine PC20 (mg/mL)", "paramType": "GEOMETRIC_MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mg/mL", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "1.85", "spread": "1.67"}, {"groupId": "BG001", "value": "2.05", "spread": "1.61"}, {"groupId": "BG002", "value": "1.95", "spread": "1.65"}]}]}]}, {"title": "Sputum eosinophils (%)", "paramType": "MEDIAN", "dispersionType": "INTER_QUARTILE_RANGE", "unitOfMeasure": "% of eosinophils", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "0.40", "lowerLimit": "0", "upperLimit": "1.30"}, {"groupId": "BG001", "value": "0.30", "lowerLimit": "0", "upperLimit": "1.30"}, {"groupId": "BG002", "value": "0.40", "lowerLimit": "0", "upperLimit": "1.30"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Treatment Failure", "description": "Treatment failure is a well-defined asthma outcome reflecting overall asthma control that has been used previously in multiple clinical trials. Treatment failure as defined in the current proposal and prior trials is consistent with the American Thoracic Society (ATS)/European Respiratory Society(ERS) definition of a moderate exacerbation - a deterioration in symptoms and/or lung function with increased rescue bronchodilator use that lasts 2 days or more. The percentages of participants experiencing a treatment failure are Kaplan-Meier estimates of failure rate.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of participants", "timeFrame": "Twenty-eight week intervention period from randomization until end of trial.", "groups": [{"id": "OG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "OG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "29", "lowerLimit": "23", "upperLimit": "35"}, {"groupId": "OG001", "value": "28", "lowerLimit": "21", "upperLimit": "34"}]}]}]}, {"type": "SECONDARY", "title": "Lung Function Change From Baseline", "description": "FEV1 (liters) and methacholine PC20 will be evaluated. Changes are measured as 28 weeks minus baseline.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Liters", "timeFrame": "Change is measured as value at 28 weeks minus baseline value.", "groups": [{"id": "OG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "OG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.04", "lowerLimit": "-0.11", "upperLimit": "0.03"}, {"groupId": "OG001", "value": "-0.07", "lowerLimit": "-0.14", "upperLimit": "0.01"}]}]}]}, {"type": "SECONDARY", "title": "Exacerbations", "description": "Outcome defined as number of exacerbations per person-year.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Exacerbations/person-year", "timeFrame": "Overall exacerbation rate during 28-week trial", "groups": [{"id": "OG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}, {"id": "OG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "207"}, {"groupId": "OG001", "value": "201"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.40", "lowerLimit": "0.30", "upperLimit": "0.50"}, {"groupId": "OG001", "value": "0.26", "lowerLimit": "0.18", "upperLimit": "0.33"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Ciclesonide + Placebo", "description": "Ciclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)", "seriousNumAffected": 9, "seriousNumAtRisk": 207, "otherNumAffected": 157, "otherNumAtRisk": 207}, {"id": "EG001", "title": "Ciclesonide + Vitamin D", "description": "Vitamin D3: vitamin D (100,000 IU loading dose followed by 4,000 IU/day)\n\nCiclesonide: Low dose inhaled corticosteroid (80 mcg/puff two puffs twice daily)", "seriousNumAffected": 6, "seriousNumAtRisk": 201, "otherNumAffected": 168, "otherNumAtRisk": 201}], "seriousEvents": [{"term": "Asthma exacerbation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 3, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Initial diagnosis of breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}, {"term": "Severe leg pain", "organSystem": "Blood and lymphatic system disorders", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}, {"term": "Sigmoid diverticulitis with abscess", "organSystem": "Gastrointestinal disorders", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}, {"term": "Gastric volvulus causing gastric outlet obstruction", "organSystem": "Gastrointestinal disorders", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Major depression disorder", "organSystem": "Psychiatric disorders", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}, {"term": "Post-traumatic stress disorder", "organSystem": "Psychiatric disorders", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Allergic reaction/rash", "organSystem": "Skin and subcutaneous tissue disorders", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}, {"term": "Benign fibroid tumor surgery", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Inguinal hernia", "organSystem": "Surgical and medical procedures", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Transient ischemic attack", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 201}]}, {"term": "Limb edema", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 201}]}], "otherEvents": [{"term": "Diseases of the digestive system", "organSystem": "Gastrointestinal disorders", "stats": [{"groupId": "EG000", "numEvents": 28, "numAffected": 23, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 20, "numAffected": 13, "numAtRisk": 201}]}, {"term": "Diseases of the genitourinary system", "organSystem": "Renal and urinary disorders", "stats": [{"groupId": "EG000", "numEvents": 31, "numAffected": 18, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 12, "numAffected": 12, "numAtRisk": 201}]}, {"term": "Diseases of the musculoskeletal system and connective tissue", "organSystem": "Musculoskeletal and connective tissue disorders", "stats": [{"groupId": "EG000", "numEvents": 46, "numAffected": 31, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 33, "numAffected": 29, "numAtRisk": 201}]}, {"term": "Diseases of the nervous system and sense organs", "organSystem": "Nervous system disorders", "stats": [{"groupId": "EG000", "numEvents": 27, "numAffected": 25, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 30, "numAffected": 23, "numAtRisk": 201}]}, {"term": "Diseases of the respiratory system", "organSystem": "Respiratory, thoracic and mediastinal disorders", "stats": [{"groupId": "EG000", "numEvents": 231, "numAffected": 122, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 253, "numAffected": 137, "numAtRisk": 201}]}, {"term": "Infectious and parasitic diseases", "organSystem": "Infections and infestations", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 22, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 13, "numAffected": 12, "numAtRisk": 201}]}, {"term": "Injury and poisoning", "organSystem": "Injury, poisoning and procedural complications", "stats": [{"groupId": "EG000", "numEvents": 31, "numAffected": 23, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 40, "numAffected": 28, "numAtRisk": 201}]}, {"term": "Symptoms, signs, and ill-defined conditions", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numEvents": 114, "numAffected": 60, "numAtRisk": 207}, {"groupId": "EG001", "numEvents": 141, "numAffected": 59, "numAtRisk": 201}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Tonya S. King, PhD", "organization": "Penn State University Dept. of Public Health Sciences", "email": "tking@psu.edu", "phone": "717-531-7178"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000014807", "term": "Vitamin D"}, {"id": "D000002762", "term": "Cholecalciferol"}, {"id": "C000120481", "term": "Ciclesonide"}], "ancestors": [{"id": "D000014815", "term": "Vitamins"}, {"id": "D000018977", "term": "Micronutrients"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000050071", "term": "Bone Density Conservation Agents"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M17550", "name": "Vitamin D", "asFound": "Acid", "relevance": "HIGH"}, {"id": "M6003", "name": "Cholecalciferol", "asFound": "Diabetic", "relevance": "HIGH"}, {"id": "M17558", "name": "Vitamins", "relevance": "LOW"}, {"id": "M221371", "name": "Ciclesonide", "asFound": "Rigid", "relevance": "HIGH"}, {"id": "M21009", "name": "Micronutrients", "relevance": "LOW"}, {"id": "M16885", "name": "Trace Elements", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}, {"id": "T479", "name": "Vitamin D3", "asFound": "Diabetic", "relevance": "HIGH"}, {"id": "T442", "name": "Cholecalciferol", "relevance": "LOW"}, {"id": "T440", "name": "Calciferol", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}, {"abbrev": "Micro", "name": "Micronutrients"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Vi", "name": "Vitamins"}]}}, "hasResults": true}